DK2807170T3 - Phragmalin-limonoider til behandlingen af seksuel dysfunktion - Google Patents
Phragmalin-limonoider til behandlingen af seksuel dysfunktion Download PDFInfo
- Publication number
- DK2807170T3 DK2807170T3 DK13702766.0T DK13702766T DK2807170T3 DK 2807170 T3 DK2807170 T3 DK 2807170T3 DK 13702766 T DK13702766 T DK 13702766T DK 2807170 T3 DK2807170 T3 DK 2807170T3
- Authority
- DK
- Denmark
- Prior art keywords
- limonoides
- phragmalin
- treatment
- sexual dysfunction
- sexual
- Prior art date
Links
- 201000001880 Sexual dysfunction Diseases 0.000 title 1
- 231100000872 sexual dysfunction Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1200052 | 2012-01-25 | ||
| SE1200678 | 2012-11-06 | ||
| SE1300011 | 2013-01-04 | ||
| PCT/EP2013/051413 WO2013110744A2 (en) | 2012-01-25 | 2013-01-25 | Novel compounds, their manufacture and uses (ii) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2807170T3 true DK2807170T3 (da) | 2019-05-27 |
Family
ID=47666104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13702766.0T DK2807170T3 (da) | 2012-01-25 | 2013-01-25 | Phragmalin-limonoider til behandlingen af seksuel dysfunktion |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9403841B2 (enExample) |
| EP (1) | EP2807170B1 (enExample) |
| CN (1) | CN104254537B (enExample) |
| AU (1) | AU2013213580B2 (enExample) |
| CA (1) | CA2861045A1 (enExample) |
| DK (1) | DK2807170T3 (enExample) |
| ES (1) | ES2723248T3 (enExample) |
| IN (1) | IN2014DN05615A (enExample) |
| NZ (1) | NZ626736A (enExample) |
| PL (1) | PL2807170T3 (enExample) |
| WO (1) | WO2013110744A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104628692B (zh) * | 2015-02-09 | 2016-02-10 | 庄爱华 | 柠檬苦素类化合物，其药物组合物及其制备方法和用途 |
| CN208336488U (zh) * | 2015-07-31 | 2019-01-04 | 株式会社村田制作所 | 线圈天线以及天线装置 |
| CN109394732A (zh) * | 2017-08-16 | 2019-03-01 | 安徽中医药大学 | 盐酸青藤碱肠溶定位渗透泵控释胶囊及其制备方法 |
| CN110903912B (zh) * | 2019-11-29 | 2022-01-28 | 华东理工大学 | 一种芳基油脂及其制备方法与应用 |
| CN111755072B (zh) * | 2020-08-04 | 2021-02-02 | 深圳吉因加医学检验实验室 | 一种同时检测甲基化水平、基因组变异和插入片段的方法及装置 |
| CN112898263B (zh) * | 2021-01-28 | 2022-03-08 | 江西中医药大学 | 一种从佛手中分离的香豆素骈木脂素化合物及其保肝用途 |
| SE2251130A1 (en) * | 2022-09-30 | 2024-03-31 | Dicot Ab | New compounds and methods of their manufacturing |
| WO2025040810A1 (en) | 2023-08-23 | 2025-02-27 | Dicot Pharma Ab | Therapeutic compounds, a method of manufacturing thereof as well as uses thereof |
| WO2025141142A1 (en) * | 2023-12-29 | 2025-07-03 | Dicot Pharma Ab | A novel method for recovering limonoid compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1318825A2 (de) | 2000-07-26 | 2003-06-18 | Vitaplant AG | Piper methysticum pflanzenextrakt |
| CN1226298C (zh) * | 2003-08-07 | 2005-11-09 | 中国科学院南海海洋研究所 | 柠檬苦素化合物－木果楝内酯及其用途 |
| JP2005213202A (ja) | 2004-01-29 | 2005-08-11 | Maruzen Pharmaceut Co Ltd | 抗酸化剤、抗老化剤及び抗炎症剤、並びに、皮膚化粧料 |
| CA2623831A1 (en) | 2005-09-12 | 2007-03-22 | Council Of Scientific And Industrial Research | An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia |
| AU2008256521B2 (en) | 2007-05-29 | 2014-09-04 | Dicot Ab | Novel compounds and pharmaceutical preparations from Neobeguea spec |
| GB0710230D0 (en) | 2007-05-30 | 2007-07-11 | Reckitt Benckiser Nv | Detergent dosing device |
| US7786171B2 (en) | 2008-04-04 | 2010-08-31 | Abbott Laboratories | Amide derivatives as positive allosteric modulators and methods of use thereof |
-
2013
- 2013-01-25 AU AU2013213580A patent/AU2013213580B2/en not_active Ceased
- 2013-01-25 NZ NZ626736A patent/NZ626736A/en not_active IP Right Cessation
- 2013-01-25 WO PCT/EP2013/051413 patent/WO2013110744A2/en not_active Ceased
- 2013-01-25 EP EP13702766.0A patent/EP2807170B1/en active Active
- 2013-01-25 IN IN5615DEN2014 patent/IN2014DN05615A/en unknown
- 2013-01-25 DK DK13702766.0T patent/DK2807170T3/da active
- 2013-01-25 ES ES13702766T patent/ES2723248T3/es active Active
- 2013-01-25 CA CA2861045A patent/CA2861045A1/en not_active Abandoned
- 2013-01-25 CN CN201380006854.4A patent/CN104254537B/zh not_active Expired - Fee Related
- 2013-01-25 PL PL13702766T patent/PL2807170T3/pl unknown
- 2013-01-25 US US14/374,356 patent/US9403841B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013213580B2 (en) | 2017-06-15 |
| EP2807170A2 (en) | 2014-12-03 |
| NZ626736A (en) | 2016-11-25 |
| CA2861045A1 (en) | 2013-08-01 |
| AU2013213580A1 (en) | 2014-07-24 |
| EP2807170B1 (en) | 2019-03-13 |
| US20150011616A1 (en) | 2015-01-08 |
| ES2723248T3 (es) | 2019-08-22 |
| IN2014DN05615A (enExample) | 2015-04-03 |
| PL2807170T3 (pl) | 2019-09-30 |
| CN104254537A (zh) | 2014-12-31 |
| WO2013110744A2 (en) | 2013-08-01 |
| CN104254537B (zh) | 2017-06-30 |
| HK1204325A1 (en) | 2015-11-13 |
| WO2013110744A3 (en) | 2013-10-31 |
| US9403841B2 (en) | 2016-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2964315T3 (da) | System til behandling af neuromotorisk dysfunktion | |
| DK3329884T3 (da) | Implanterbar indretning til behandling af glaukom | |
| DK3076967T3 (da) | Fremgangsmåder til behandling af residuelle symptomer på skizofreni | |
| DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
| DK2919796T3 (da) | Brug af akkermansia til behandling af stofskiftesygdomme | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| HRP20180237T1 (hr) | Metode za liječenje hcv-a | |
| LT2885010T (lt) | Tautopatijos gydymo būdai | |
| DK2983787T3 (da) | Fremgangsmåde til behandling af posttraumatisk stresssygdom | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| DK3305317T3 (da) | Forbindelser til behandling af neuropsykiatriske forstyrrelser | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
| SI2707029T1 (sl) | Metode zdravljenja ali preprečevanja s holesterolom povezanih motenj | |
| HUE037048T2 (hu) | Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására | |
| DK3021838T3 (da) | Behandling af fedme | |
| DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
| DK2854769T3 (da) | Fremgangsmåder til behandling af artritis | |
| DK2807170T3 (da) | Phragmalin-limonoider til behandlingen af seksuel dysfunktion | |
| DK2976359T4 (da) | Fremgangsmåder til behandling af osteogenesis imperfecta | |
| DK2818241T3 (da) | Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| LT3007726T (lt) | Tautopatijos gydymo būdai | |
| DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom |